Literature DB >> 22165035

Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.

Suzanne Nielsen1, Jacqui Cameron, Nicole Lee.   

Abstract

OBJECTIVES: Recently, there has been considerable policy and public interest in the availability of over-the-counter (OTC) codeine. Case reports demonstrating severe harm from OTC codeine have been published. However, few studies have examined how people use these products and who develops dependence. The aim of this study was to better understand who develops problematic use of OTC codeine. DESIGN AND
SETTING: The authors conducted a web-based survey with people who self-reported OTC codeine use. Eight hundred participants completed the survey that examined codeine use and dependence, pain, and general physical and mental health.
RESULTS: Codeine-dependent people differed from nondependent codeine users on a range of characteristics. They were younger, had lower levels of employment and education, and were more likely to report family history of substance dependence. They were more likely to have taken well above recommended doses of OTC codeine and have taken codeine for considerably longer periods of time than recommended. Codeine-dependent people in this study differed markedly from other populations of opioid-dependent people recruited to research in Australia and were more similar to the general population, suggesting that a web-based survey may have reached an under-researched population of opioid-dependent people.
CONCLUSIONS: How best to use these findings to identify at-risk OTC codeine users requires consideration. Approaches aimed at reducing harm from prescription opioids may be difficult to implement in pharmacy settings. Implications for pharmacists and other health professionals are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22165035

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  8 in total

1.  Changes for codeine.

Authors:  Darren M Roberts; Suzanne Nielsen
Journal:  Aust Prescr       Date:  2018-01-23

2.  An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.

Authors:  Natasa Gisev; Suzanne Nielsen; Elena Cama; Briony Larance; Raimondo Bruno; Louisa Degenhardt
Journal:  Eur J Clin Pharmacol       Date:  2015-12-22       Impact factor: 2.953

3.  Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users.

Authors:  João Mauricio Castaldelli-Maia; Laura H Andrade; Katherine M Keyes; Magdalena Cerdá; Daniel J Pilowsky; Silvia S Martins
Journal:  J Psychiatr Res       Date:  2016-05-24       Impact factor: 4.791

Review 4.  Opioid agonist treatment for people who are dependent on pharmaceutical opioids.

Authors:  Suzanne Nielsen; Wai Chung Tse; Briony Larance
Journal:  Cochrane Database Syst Rev       Date:  2022-09-05

5.  'I can't be an addict. I am.' Over-the-counter medicine abuse: a qualitative study.

Authors:  Richard J Cooper
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  From pain treatment to opioid dependence: a qualitative study of the environmental influence on codeine use in UK adults.

Authors:  Emma Kinnaird; Andreas Kimergård; Stacey Jennings; Colin Drummond; Paolo Deluca
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

7.  The Severity of Dependence Scale (SDS) for Codeine: Preliminary Investigation of the Psychometric Properties of the SDS in an Online Sample of Codeine Users From the UK.

Authors:  Paolo Deluca; Michelle Foley; Jacklyn Dunne; Andreas Kimergård
Journal:  Front Psychiatry       Date:  2021-04-01       Impact factor: 4.157

8.  A comparative analysis of pharmacists' perspectives on codeine use and misuse - a three country survey.

Authors:  Tara Carney; John Wells; Charles D H Parry; Padraig McGuinness; Richard Harris; Marie Claire Van Hout
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.